UBC is an industry leader in the design and execution of research on comparative effectiveness and value. Our experts are focused on addressing the need for rigorous evidence of product value in today’s cost constrained health care environment.
Our researchers are dedicated to understanding the public policy issues that drive the modern health care market. UBC scientists participate in a range of public and private initiatives to understand and deploy comparative effectiveness research in the market. We are well positioned to provide strategic counsel and implementation expertise to organizations that are managing the implications of comparative effectiveness and value policies.
We help clients leverage comparative effectiveness research to improve the practicality and efficiency of comparative clinical studies and address mounting “real-world” evidentiary demands by payers, clinicians and policy makers. It was for this reason that we launched the Pragmatic Approaches to Comparative Effectiveness (PACE) Initiative in January of 2008. PACE is a collaborative effort between therapeutic manufacturers, academic researchers, and other organizations to stimulate discussion, raise awareness, and promote development and consensus around comparative effectiveness research methodologies. PACE was created in the belief that whereas the comparative effectiveness national agenda must include comparative and pragmatic trials, traditional approaches to designing and conducting such trials are too costly, take too much time and are commonly not answering real world needs. PACE investigators are exploring the challenges and opportunities, in particular, of Bayesian and adaptive trial techniques as applied to real world comparative effectiveness applications.
Our services related to comparative effectiveness issues and objectives include:
